Compared to placebo, significant weight reductions were observed with GLP-1 RAs/metformin (WMD: 6.65
Even in conditions where albumin levels can be low (e.g., hepatic impairment, nephrotic syndrome), albumin is still not expected to decrease to levels that could directly impact tirzepatide PK
Your provider should document clear clinical indication (type 2 diabetes or obesity with BMI 27 + comorbidity)
Prescription approval is determined by a licensed clinician, not the SkinnyRx platform
While both methods aim to increase your B12 levels, they operate on very different timelines and through different biological pathways
However, translating a biochemical role into a predictable clinical result (like weight loss) requires strong human trial evidence, which is limited for MIC injection blends